• Health Catalyst Invests In healthfinch

    To kick off the third quarter, Health Catalyst has announced its second acquisition of 2020. On July 9, the company announced it acquired healthfinch, Inc. for roughly $40 million. healthfinch provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in... Read More »
  • Second Quarter Healthcare M&A Activity Drops

    The decline in second quarter healthcare M&A probably won’t surprise many of our readers. The second quarter was the first full quarter of healthcare M&A in the shadow of the COVID-19 pandemic, and deal making took a hit as a result, as shown in results from our DSO database. Compared with Q1:20, Q2:20 dropped 20%, with 322 transactions... Read More »
  • Sanofi Inks New Licensing Deal

    Just weeks following its agreement with Translate Bio (NASDAQ: TBIO) for COVID-19 vaccine development, Sanofi (NYSE: SNY) has a new agreement with Kymera Therapeutics Inc. Sanofi and Kymera are signing a multi-program collaboration to develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with... Read More »
  • Summit BHC Expands Into West Virginia

    Private equity-backed Summit BHC has announced a new acquisition in West Virginia. The behavioral health treatment company added Highland Hospital to its network for an undisclosed sum. Meridian Behavioral Health Systems, LLC is selling Highland Hospital, an inpatient psychiatric facility (131 beds) with 24 beds dedicated to psychiatric... Read More »
  • Health Care M&A Deals, July 10, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week based on... Read More »
Mednax Sells MedData, Pulls Back on M&A

Mednax Sells MedData, Pulls Back on M&A

It’s been nearly a year since Mednax Inc. (NYSE: MD) announced its MedData subsidiary was headed for the auction block. The company acquired the privately held revenue cycle management company in August 2014 for an undisclosed amount. Now that Mednax has hired teams of consultants to help it rethink its business model, MedData is a non-core asset. Frazier Healthcare Partners agreed to pay $250 million for MedData in mid-October, although Mednax has classified MedData as discontinued operations since the first quarter of 2019. The target provides management services to hospitals, health systems and healthcare providers. Back in 2014, when Mednax bought it, MedData served 3,000 physicians at... Read More »
U.S. Renal Care Gets Big New Backers

U.S. Renal Care Gets Big New Backers

U.S. Renal Care has new owners, as of February 13. It marks the first renal-related transaction in 2019 and it won’t be the last. The national dialysis provider was backed by a consortium of private equity firms such as Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates and Cressey & Company. Stepping in to take over is Bain Capital Private Equity, Summit Partners and Revelstoke Partners, with participation by the company’s executive management team. Financial terms were not disclosed, naturally. U.S. Renal Care works with nephrologists to develop, acquire and operate outpatient treatment centers for people suffering from chronic kidney... Read More »
TA Associates Climbs on the Autism Bandwagon

TA Associates Climbs on the Autism Bandwagon

Autism disorders are big business these days, as private equity firms flock to the subsector. More than 40 deals targeting all manner of autism services have been announced since the beginning of 2014. Of those, 17 were direct investments by firms such as Frazier Healthcare Partners (August 2018) and Pharos Capital Group (November 2018) and 14 were follow-on deals. The latest to join the parade is TA Associates, which just announced its acquisition of Behavioral Health Works (BHW) in Anaheim, California. Like many other autism services providers, BHW specializes in Applied Behavioral Analysis (ABA) therapy and ancillary services for children with autism spectrum disorder and related... Read More »
October 2018 Healthcare Deal Spending Breaks Even

October 2018 Healthcare Deal Spending Breaks Even

Spending on healthcare deals in the month of October didn’t match the surge in deal volume (see separate post). At $9.4 billion, October 2018 posted a slight 4% gain over September, but was 25% lower than the $12.6 billion spent in October 2017. Of course, we can only go by disclosed prices, and several transactions that did not disclose financial terms would probably boost the month’s total by at least a few billion dollars. H.I.G. Capital’s acquisition of Correct Care Solutions, is a case in point. Co-owners Audax, GTCR and Frazier Healthcare sold Correct Care, which provides medical and behavioral health services for nearly 250,000 patients in 38 U.S. states and in Australia. Only... Read More »
Tailwind Capital Takes Over Abode Healthcare

Tailwind Capital Takes Over Abode Healthcare

The Home Health & Hospice sector is experiencing strong tailwinds this year, with at least 38 transactions announced through May 25. In all of 2017, 62 deals were announced in this sector. Seven of this year’s transactions were direct acquisitions by private equity firms, with Blue Wolf Capital and Stonehenge Partners announcing two deals each. In May, Tailwind Capital, a New York City-based middle market private equity firm, announced its acquisition of Abode Healthcare, based in Durango, Arizona. Abode Healthcare, a portfolio company of Frazier Healthcare Partners, provides a full spectrum of patient-centric hospice and home health services in growing markets in 10 states. The... Read More »